Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,261
Total Claims
$3.4M
Drug Cost
590
Beneficiaries
$5,769
Cost/Patient
Risk Score Breakdown 38/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
+17%
Opioid rate vs peers
2.9% vs 2.5% avg
+411%
Cost per patient vs peers
$5,769 vs $1,128 avg
+160%
Brand preference vs peers
21.8% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.9%
Opioid Rate
557
Opioid Claims
$47K
Opioid Cost
15.3%
Long-Acting Rate
Brand vs Generic
Brand: 4,141 claims · $3.0M
Generic: 14,816 claims · $382K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 289 | $355K |
| Apixaban | 356 | $323K |
| Empagliflozin | 229 | $235K |
| Dulaglutide | 120 | $154K |
| Insulin Degludec/Liraglutide | 87 | $124K |
| Dapagliflozin Propanediol | 154 | $124K |
| Insulin Degludec | 110 | $101K |
| Empagliflozin/Metformin Hcl | 124 | $97K |
| Deutetrabenazine | 13 | $79K |
| Icosapent Ethyl | 141 | $75K |
| Linaclotide | 86 | $74K |
| Tirzepatide | 60 | $66K |
| Dapaglifloz Propaned/Metformin | 77 | $56K |
| Budesonide/Glycopyr/Formoterol | 73 | $55K |
| Canagliflozin | 61 | $47K |
Prescribing Profile
Patient Profile
71
Avg Age
56%
Female
1.36
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About